Replies to post #12874 on Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

BR, I can live with that, although I think it will fetch more than that given the fact that it has a 16 year patent life and nobody in sight to compete with this unmet medical need drug, so they will have a kind of monopoly for LN in the next several years. The prospective buyer can pursue SLE, VOS, and other cyclosporine treated conditions. They can’t go wrong with a proven stellar drug. It won’t be long, yeah…

[Zeppo]

Aurinia rather quietly hired a new member for the management team. This lady has a bunch of M & A experience, and, I'll bet, a bunch of the right connections. Worth checking out.